|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 198.91 USD | -0.72% |
|
-7.96% | +13.02% |
| 08/07 | Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says | MT |
| 08/07 | BofA Securities Adjusts Biogen Price Target to $217 From $203 | MT |
| Market Cap | 2.94TCr 2.57TCr 2.37TCr 2.19TCr 4.16TCr 2,80300Cr 4.23TCr 28TCr 11TCr 1,37700Cr 11TCr 11TCr 4,76800Cr | P/E 2026 * |
30.3x | P/E 2027 * | 16.7x |
|---|---|---|---|---|---|
| Enterprise Value | 3.49TCr 3.05TCr 2.81TCr 2.6TCr 4.94TCr 3,32900Cr 5.02TCr 34TCr 13TCr 1,63500Cr 13TCr 13TCr 5,66200Cr | EV / Sales 2026 * |
3.47x | EV / Sales 2027 * | 3.15x |
| Free-Float |
85.96% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Biogen Inc.
| 1 day | -0.72% | ||
| 1 week | -7.96% | ||
| Current month | -7.94% | ||
| 1 month | -0.10% | ||
| 3 months | +12.31% | ||
| 6 months | +6.02% | ||
| Current year | +13.02% |
| 1 week | 196 |  | 215.95 |
| 1 month | 193.2 | | 219.72 |
| Current year | 160.36 | | 219.72 |
| 1 year | 121.05 | | 219.72 |
| 3 years | 110.04 | | 281.68 |
| 5 years | 110.04 | | 358.77 |
| 10 years | 110.04 | | 468.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 66 | 14/11/2022 | |
Robin Kramer
DFI | Director of Finance/CFO | 60 | 01/03/2025 |
Guy Hadari
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Eric Rowinsky
BRD | Director/Board Member | 69 | 23/03/2010 |
Stephen Sherwin
BRD | Director/Board Member | 77 | 01/01/2010 |
William Hawkins
BRD | Director/Board Member | 72 | 19/06/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 09/06 | Free | Chairman | 2,005 | 0.0014% | ||
| 09/06 | Fiscal year | Director | 6,245 | 0.0042% | ||
| 09/06 | Free | Director | 1,505 | 0.0010% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.72% | -7.96% | +49.53% | -27.69% | 2.94TCr | |
| +0.76% | +2.09% | +20.88% | -3.54% | 6.8TCr | |
| 0.00% | -3.66% | +44.84% | +218.71% | 5.44TCr | |
| -2.10% | +0.89% | -49.30% | -53.47% | 4.17TCr | |
| -2.79% | +32.50% | +32.50% | +32.50% | 4.06TCr | |
| +3.74% | -4.01% | +133.49% | -35.59% | 3.04TCr | |
| +1.07% | +1.42% | +72.47% | +90.95% | 2.37TCr | |
| +3.88% | +2.16% | +11.78% | +201.51% | 1.92TCr | |
| +15.12% | +16.82% | +96.11% | +433.87% | 1.77TCr | |
| +0.04% | +0.21% | +64.05% | +135.06% | 1.71TCr | |
| Average | +0.26% | +0.53% | +47.63% | +99.23% | 3.42TCr | |
| Weighted average by Cap. | -0.02% | -0.36% | +39.08% | +72.64% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.01TCr 879.52Cr 811.06Cr 750.44Cr 1.42TCr 96TCr 1.45TCr 9.71TCr 3.81TCr 47TCr 3.77TCr 3.69TCr 1,63200Cr | 1.04TCr 908.39Cr 837.69Cr 775.07Cr 1.47TCr 99TCr 1.5TCr 10TCr 3.93TCr 49TCr 3.9TCr 3.81TCr 1,68600Cr |
| Net income | 149.48Cr 130.77Cr 120.59Cr 111.57Cr 211.77Cr 14TCr 215.31Cr 1.44TCr 566.1Cr 7.01TCr 561.17Cr 549.03Cr 24TCr | 196.89Cr 172.24Cr 158.83Cr 146.96Cr 278.94Cr 19TCr 283.6Cr 1.9TCr 745.63Cr 9.23TCr 739.14Cr 723.15Cr 32TCr |
| Net Debt | 550.87Cr 481.9Cr 444.4Cr 411.18Cr 780.43Cr 53TCr 793.48Cr 5.32TCr 2.09TCr 26TCr 2.07TCr 2.02TCr 89TCr | 338.49Cr 296.11Cr 273.06Cr 252.65Cr 479.54Cr 32TCr 487.56Cr 3.27TCr 1.28TCr 16TCr 1.27TCr 1.24TCr 55TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/26/09 | $198.91 | -0.72% | 16,57,327 |
| 08/26/08 | $200.36 | -2.60% | 19,47,888 |
| 07/26/07 | $205.70 | -1.32% | 11,56,880 |
| 06/26/06 | $208.46 | -3.54% | 12,18,492 |
| 02/26/02 | $216.12 | +3.04% | 11,55,165 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BIIB Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
